Stroma-induced phenotypic plasticity offers phenotype-specific targeting to improve melanoma treatment
نویسندگان
چکیده
منابع مشابه
Targeting Both Tumor and Stroma Cells to Treat Melanoma: NIPAWILMA.
All patients enrolled in either phase I or phase II will be treated according to the following treatment plan: Week 1–24: Chemotherapy with paclitaxel combined with nintedanib/placebo Week 25–48: Extended monotherapy with nintedanib/placebo Week 52 (or approximately 4 weeks after last treatment dose): End-of-treatment visit. Follow up: After end of treatment the survival, disease status and fur...
متن کاملTrait-specific consequences of inbreeding on adaptive phenotypic plasticity
Environmental changes may stress organisms and stimulate an adaptive phenotypic response. Effects of inbreeding often interact with the environment and can decrease fitness of inbred individuals exposed to stress more so than that of outbred individuals. Such an interaction may stem from a reduced ability of inbred individuals to respond plastically to environmental stress; however, this hypoth...
متن کاملFOXO Regulates Organ-Specific Phenotypic Plasticity In Drosophila
Phenotypic plasticity, the ability for a single genotype to generate different phenotypes in response to environmental conditions, is biologically ubiquitous, and yet almost nothing is known of the developmental mechanisms that regulate the extent of a plastic response. In particular, it is unclear why some traits or individuals are highly sensitive to an environmental variable while other trai...
متن کاملFoxo Regulates Organ - Specific Phenotypic Plasticity in 1 " Drosophila
10" Phenotypic plasticity, the ability for a single genotype to generate different phenotypes in 11" response to environmental conditions, is biological ubiquitous and yet almost nothing is 12" known of the developmental mechanisms that regulate the extent of a plastic response. In 13" particular, it is unclear why some traits or individuals are highly sensitive to an 14" environmental variable...
متن کاملTargeting KIT for Treatment Of Advanced Melanoma
This is a remarkable time for melanoma research and treatment. Before this year, approved agents available for the treatment of metastatic melanoma were limited to dacarbazine (DTIC) and interleukin-2 (IL-2), with benefits achieved in only a small minority of patients treated with either drug. In 2011, however, two new agents, ipilimumab (YervoyTM) and vemurafenib (ZelborafTM), were approved, w...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer Letters
سال: 2018
ISSN: 0304-3835
DOI: 10.1016/j.canlet.2018.09.023